Trial Profile
The placebo controlled randomized double blind multicenter study to investigate effectiveness and safety of combination use of melatonin receptor agonist for dose reduction or interruptions of BZD and non-BZD hypnotics on chronic insomnia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2020
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 31 Aug 2020 Status changed from active, no longer recruiting to completed.
- 01 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2018 Status changed from not yet recruiting to recruiting.